You are here: Industry Insights > Luminex

News List

Luminex Files EUA for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2 americanpharmaceuticalreview
July 29, 2020
Luminex has submitted an EUA request to the U.S. Food and Drug Administration (FDA) for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing.
Luminex Receives EUA for COVID-19 Antibody Test americanpharmaceuticalreview
July 27, 2020
Luminex announced the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's xMAP® SARS-CoV-2 Multi-Antigen IgG Assay.
Luminex Receives Emergency Use Authorization for ARIES® SARS-CoV-2 Assay americanpharmaceuticalreview
April 10, 2020
Luminex announced the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its ARIES® SARS-CoV-2 Assay.
Luminex Receives EUA for NxTAG® CoV Extended Panel to Detect SARS-CoV-2 americanpharmaceuticalreview
April 01, 2020
Luminex announced the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its NxTAG® CoV Extended Panel.
Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts americanpharmaceuticalreview
March 16, 2020
Luminex announced that four independent clinical laboratories have validated laboratory developed tests (LDTs) for automated.
Luminex Submits ARIES MRSA Assay for FDA Clearance americanpharmaceuticalreview
July 04, 2019
Luminex announced the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance. The assay is a real-time, quantitative polymerase chain reaction (qPCR)-based...